No Data
No Data
Jefferies Releases a Buy Rating on Nuvation Bio (NUVB)
Nuvation Bio Is Maintained at Buy by HC Wainwright & Co.
H.C. Wainwright Maintains Nuvation Bio(NUVB.US) With Buy Rating, Cuts Target Price to $7
H.C. Wainwright analyst Robert Burns maintains $Nuvation Bio(NUVB.US)$ with a buy rating, and adjusts the target price from $8 to $7.According to TipRanks data, the analyst has a success rate of 30.9%
Express News | Nuvation Bio Inc. : H.c. Wainwright Cuts Target Price to $7 From $8
Reported Saturday, Nuvation Bio Announces Pooled Data From TRUST-I And TRUST-II Studies, Highlighting Taletrectinib's Best-In-Class Potential For Advanced ROS1-Positive NSCLC
Wedbush Reiterates Outperform on Nuvation Bio, Maintains $5 Price Target